- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Patent holdings for IPC class C12Q 1/6883
Total number of patents in this class: 7377
10-year publication summary
|
245
|
298
|
627
|
776
|
823
|
810
|
851
|
871
|
767
|
462
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4264 |
169 |
| The Regents of the University of California | 19918 |
133 |
| Natera, Inc. | 320 |
128 |
| The Board of Trustees of the Leland Stanford Junior University | 6408 |
96 |
| Cedars-Sinai Medical Center | 1156 |
76 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
69 |
| The Johns Hopkins University | 5667 |
63 |
| The Children's Hospital of Philadelphia | 788 |
58 |
| The Brigham and Women's Hospital, Inc. | 2188 |
50 |
| The General Hospital Corporation | 4733 |
49 |
| The Chinese University of Hong Kong | 152 |
47 |
| President and Fellows of Harvard College | 5976 |
44 |
| Centre National de La Recherche Scientifique | 10418 |
43 |
| Yale University | 2378 |
43 |
| The Broad Institute, Inc. | 1808 |
41 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2822 |
41 |
| Duke University | 3066 |
36 |
| Celera Corporation | 78 |
31 |
| Sequenom, Inc. | 274 |
31 |
| Seoul National University R&db Foundation | 3597 |
31 |
| Other owners | 6098 |